S423-0615 Screening compound: 3-{2-[4-(2-methoxyethoxy)-1-oxa-9-azaspiro[5.5]undecan-9-yl]-2-oxoethyl}-2,3-dihydro-1,3-benzoxazol-2-one

S423-0615 Screening compound: 3-{2-[4-(2-methoxyethoxy)-1-oxa-9-azaspiro[5.5]undecan-9-yl]-2-oxoethyl}-2,3-dihydro-1,3-benzoxazol-2-one
S423-0615 Screening compound: 3-{2-[4-(2-methoxyethoxy)-1-oxa-9-azaspiro[5.5]undecan-9-yl]-2-oxoethyl}-2,3-dihydro-1,3-benzoxazol-2-one alternative view

Chemical Structure Depiction of ChemDiv screening compound S423-0615
3-{2-[4-(2-methoxyethoxy)-1-oxa-9-azaspiro[5.5]undecan-9-yl]-2-oxoethyl}-2,3-dihydro-1,3-benzoxazol-2-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S423-0615

Molecular Formula

C21H28N2O6 (C21 H28 N2 O6)

Compound Name

3-{2-[4-(2-methoxyethoxy)-1-oxa-9-azaspiro[5.5]undecan-9-yl]-2-oxoethyl}-2,3-dihydro-1,3-benzoxazol-2-one

IUPAC name

3-{2-[4-(2-methoxyethoxy)-1-oxa-9-azaspiro[5.5]undecan-9-yl]-2-oxoethyl}-23-dihydro-13-benzoxazol-2-one

SMILES

COCCOC1CC(CC2)(CCN2C(CN(c(cccc2)c2O2)C2=O)=O)OCC1

InChI

InChI=1S/C21H28N2O6/c1-26-12-13-27-16-6-11-28-21(14-16)7-9-22(10-8-21)19(24)15-23-17-4-2-3-5-18(17)29-20(23)25/h2-5,16H,6-15H2,1H3/t16-/m1/s1

InChI Key

UGFUBCNQSOUPJP-MRXNPFEDSA-N

MDL Number (MFCD)

MFCD29006274

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

404.46

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

0.684

Distribution Coefficient, logD

0.684

Water Solubility, LogSw

-1.67

Polar Surface Area

61.335

Acid Dissociation Constant (pKa)

21.85

Base Dissociation Constant (pKb)

1.37

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

61.90

S423-0615 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Epigenetic
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Cyclic compounds
Targets:
  • Others

References: we are preparing a list of scientific research reports with S423-0615 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S423-0615?
Check Price and Availability of S423-0615, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S423-0615 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S423-0615
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S423-0615
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S423-0615 available by request